|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers. |
| 公司地址
| 4 Science Park, New Haven, CT, USA, 06511 |
| 電話號碼
| +1 203 787-7888 |
| 傳真號碼
| +1 203 901-1289 |
| 公司網頁
| https://www.precipiodx.com |
| 員工數量
| 60 |
| Mr. Ahmed Zaki Sabet |
Chief Operating Officer |
美元 200.00K |
30/04/2025 |
| Dr. Ayman A. Mohamed |
Chief Technology Officer |
美元 200.00K |
30/04/2025 |
| Mr. Ilan Danieli |
Director and Chief Executive Officer |
美元 300.00K |
30/04/2025 |
| Mr. Matthew Gage |
Chief Financial Officer and Principal Accounting Officer |
-- |
30/04/2025 |
|
|
| Mr. David S. Cohen |
Independent Director |
30/04/2025 |
| Dr. Jeffrey Cossman, M.D. |
Independent Director |
30/04/2025 |
| Mr. Richard A. Sandberg |
Chairman of the Board |
30/04/2025 |
| Mr. Ilan Danieli |
Director and Chief Executive Officer |
30/04/2025 |
| Mr. Ronald A. Andrews, Jr |
Independent Director |
30/04/2025 |
| Ms. Christina Valauri |
Independent Director |
30/04/2025 |
| Ms. Kathleen D. Laporte |
Independent Director |
30/04/2025 |
|
|
|
|
